You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Penicillin-susceptible Staphylococcus aureus (PSSA)

Showing 1 - 25 of 1,507
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)

Recruiting
  • Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
  • Paris, France
    François-Xavier Lescure
Dec 7, 2022

Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)

Not yet recruiting
  • Staphylococcus Aureus Bacteremia
  • +3 more
  • Montreal, Quebec, Canada
    McGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022

Staphylococcus Aureus Bacteremia Trial in Worldwide (Cefazolin, Penicillin, Clindamycin)

Recruiting
  • Staphylococcus Aureus Bacteremia
  • Garran, Australia Capital Territory, Australia
  • +73 more
Feb 23, 2022

Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide

Recruiting
  • Methicillin-Resistant Staphylococcus Aureus
  • +2 more
  • Dalbavancin single dose
  • +2 more
  • Mobile, Alabama
  • +26 more
Jan 27, 2023

Methicillin Susceptible Staphylococcus Aureus Septicemia, Bacteremia Trial in Montreal (Daptomycin, Placebo)

Completed
  • Methicillin Susceptible Staphylococcus Aureus Septicemia
  • Bacteremia
  • Montreal, Quebec, Canada
    McGill University Health Centre (Royal Victoria Hospital, Montre
Sep 18, 2020

Hemodialysis Catheter Infection, Infection, Bacterial Trial in Orléans, Tours (Blood samples)

Not yet recruiting
  • Hemodialysis Catheter Infection
  • Infection, Bacterial
  • Blood samples
  • Orléans, France
  • +1 more
Oct 16, 2023

Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU

Not yet recruiting
  • Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
  • FLU or CZO as continuous infusion
  • standard FLU or CZO intermittent bolus administration
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Dec 14, 2022

Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection Trial (Clindamycin, Standard of care)

Not yet recruiting
  • Skin Infection
  • +2 more
  • (no location specified)
Jun 15, 2023

Bacteremia Trial in Columbus (Telavancin, Vancomycin, Daptomycin)

Terminated
Has Results
  • Bacteremia
  • Columbus, Ohio
    Remington-Davis Clinical Research
Feb 13, 2020

Diabetic Foot Infection Trial (TP-102, Placebo)

Not yet recruiting
  • Diabetic Foot Infection
  • TP-102
  • Placebo
  • (no location specified)
Jul 6, 2023

Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents Trial in Seongnam-si, Seoul (N-Rephasin® SAL200, Placebo)

Terminated
Has Results
  • Staphylococcus Aureus Bacteremia
  • Anti-Bacterial Agents
  • N-Rephasin® SAL200
  • Placebo
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Sep 12, 2021

Meticillin-susceptible Staphylococcal Infective Endocarditis:

Completed
  • Infectious Disease
  • Endocarditis
    • Metz-Tessy, France
      Centre Hospitalier Annecy Genevois
    Jul 21, 2022

    Penicillin Allergy, Surgical Prophylaxis Trial in Shatin (Detailed penicillin allergy evaluation)

    Recruiting
    • Penicillin Allergy
    • Surgical Prophylaxis
    • Detailed penicillin allergy evaluation
    • Shatin, Hong Kong
      Prince of Wales Hospital
    Apr 19, 2023

    Bone or Joint Infection Trial in Ukraine, United States (Afabicin (Part A), Standard of Care, Afabicin (Part B))

    Recruiting
    • Bone or Joint Infection
    • Afabicin (Part A)
    • +2 more
    • Sacramento, California
    • +13 more
    Sep 29, 2022

    Probability of Target Attainment With Standard Intermittent

    Completed
    • Staphylococcus Aureus Infection
    • Blood samples for the measurement of the concentration of cefazolin
    • +4 more
    • Basel, Switzerland
      University Hospital Basel, Division of Internal Medicine
    Mar 28, 2022

    Staphylococcal Bacteraemia Trial in Canada, United States (Cefazolin, Dalbavancin, Daptomycin)

    Recruiting
    • Staphylococcal Bacteraemia
    • Birmingham, Alabama
    • +22 more
    Jul 28, 2022

    Catheter Bacteremia, Staphylococcus Aureus Infection Trial (Dalbavancin, Standard of care)

    Withdrawn
    • Catheter Bacteremia
    • Staphylococcus Aureus Infection
    • (no location specified)
    Jul 19, 2022

    Diabetic Foot, Staphylococcal Infections Trial in France (Topical anti-Staphylococcus bacteriophage therapy, Topical

    Not yet recruiting
    • Diabetic Foot
    • Staphylococcal Infections
    • Topical anti-Staphylococcus bacteriophage therapy
    • Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
    • Bordeaux, France
    • +8 more
    Feb 2, 2022

    Staphylococcus Aureus Bacteremia, Infective Endocarditis Trial (Echocardiography evaluation)

    Not yet recruiting
    • Staphylococcus Aureus Bacteremia
    • Infective Endocarditis
    • Echocardiography evaluation
    • (no location specified)
    May 7, 2023

    Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)

    Not yet recruiting
    • Staphylococcus Aureus
    • Carbapenem Resistant Gram Negative Bacteria
    • Targeted gown and gloves use
    • (no location specified)
    Oct 26, 2021

    Modification of Antibiotic Susceptibility Testing on Antibiotic

    Recruiting
    • Antibiotic Resistant Infection
    • Vandoeuvre les nancy, France
      CHRU Nancy
    Jun 12, 2023

    Penicillin Allergy Trial (Amoxicillin)

    Not yet recruiting
    • Penicillin Allergy
    • (no location specified)
    Jul 15, 2022

    Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109

    Completed
    • Nasal Decolonization of Staphylococcus Aureus
    • Vehicle gel, 4 + 4 applications or 4 + 2 applications
    • +2 more
    • Uppsala, Sweden
      ClinSmart Sweden AB
    May 25, 2023

    Patients With Infection by Resistant Microorganism

    Enrolling by invitation
    • Pneumonia
    • +10 more
    • Pathogen resistant phenotype
    • Sevilla, Spain
      Hospital Universitario Virgen Macarena
    May 18, 2023

    Ventilator Associated Pneumonia, Staphylococcus Aureus Trial in Limoges (Suvratoxumab, Placebo)

    Recruiting
    • Ventilator Associated Pneumonia
    • Staphylococcus Aureus
    • Suvratoxumab
    • Placebo
    • Limoges, France
      Research Site
    Feb 1, 2023